Financial Press Releases

November 22, 2022 at 4:15 PM EST

Summary Toggle Humana Completes Aggregate $1.25 Billion Debt Offering

LOUISVILLE, Ky. --(BUSINESS WIRE)--Nov. 22, 2022-- Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company’s 5.750 percent senior

Humana - November 2022 Notes - Press Release 205.8 KB
November 7, 2022 at 8:45 PM EST

Summary Toggle Humana Prices $1.25 Billion Debt Offering

LOUISVILLE, Ky. --(BUSINESS WIRE)--Nov. 7, 2022-- Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company’s 5.75 percent senior notes,

PDF Version 220.4 KB
November 2, 2022 at 6:30 AM EDT

Summary Toggle Humana Reports Third Quarter 2022 Financial Results; Affirms Recent Upward Revision to Full Year 2022 Adjusted EPS Financial Guidance

Reports 3Q22 earnings per diluted common share of $9.39 on a GAAP basis, Adjusted EPS of $6.88 ; reports YTD 2022 EPS of $22.16 on a GAAP basis, $23.58 on an Adjusted basis Updates FY 2022 EPS guidance to 'approximately $23.27 ' on a GAAP basis; affirms recent $0.25 per share upward revision to

Detailed 3Q22 Earnings Release 673.2 KB
October 27, 2022 at 4:30 PM EDT

Summary Toggle Humana Board Declares Payment of Quarterly Dividend to Stockholders

LOUISVILLE, Ky. --(BUSINESS WIRE)--Oct. 27, 2022-- Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.7875 per share payable on January 27, 2023 to stockholders of record as of the close of business on December 30, 2022 .

Dividend Announcement 208.5 KB
October 7, 2022 at 9:15 AM EDT

Summary Toggle For Second Time, Humana Kentucky Medicare Advantage HMO Plan Achieves Prestigious 5-Star Rating

LOUISVILLE, Ky. --(BUSINESS WIRE)--Oct. 7, 2022-- Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, has announced that its Kentucky HMO plan has received the highest possible quality rating for the 2023 plan year from the Centers for Medicare and Medicaid

PDF Version 635 KB
October 7, 2022 at 8:15 AM EDT

Summary Toggle For Third Time, Humana Tennessee Medicare Advantage HMO Attains Medicare’s Highest Rating for 2023

Achieving the highest possible rating of 5 stars means members in the statewide plan are not only highly satisfied with Humana, but are also receiving quality health care from clinicians who make them feel respected and valued NASHVILLE, Tenn. --(BUSINESS WIRE)--Oct.

PDF Version 811.1 KB
October 7, 2022 at 7:15 AM EDT

Summary Toggle Humana Louisiana Medicare Advantage Plan Receives Highest Possible Rating for Two Years in a Row

NEW ORLEANS --(BUSINESS WIRE)--Oct. 7, 2022-- Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, has announced that its statewide Louisiana Medicare Advantage HMO plan has received a top 5-star rating from the Centers for Medicare and Medicaid Services (CMS) for a

PDF Version 640 KB
October 7, 2022 at 6:30 AM EDT

Summary Toggle 96% of Humana’s Medicare Advantage Members are in Contracts rated 4-Star or Above for 2023; 66% are in Contracts Rated 4.5-Star or Higher

Humana received a 5 out of 5-star rating for HMO plans in Louisiana , Tennessee and Kentucky , covering approximately 356,000 members Humana received a 4.5-star rating for Medicare Advantage contracts offered in 46 states and Puerto Rico , covering more than 3 million members, nearly double last

PDF Version 857.1 KB
October 3, 2022 at 4:30 PM EDT

Summary Toggle Humana Inc. to Release Third Quarter 2022 Results on November 2, 2022

LOUISVILLE, Ky. --(BUSINESS WIRE)--Oct. 3, 2022-- Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2022 (3Q22) on Wednesday, November 2, 2022 , at 6:30 a.m. Eastern time . The company will host a conference call at 9:00 a.m.

HUM 3Q22 Release Date Announcement 217 KB
September 15, 2022 at 7:00 AM EDT

Summary Toggle Humana Introduces Mid-Term Adjusted EPS Target of $37 in 2025 and Raises Full Year 2022 Adjusted EPS Financial Guidance to ‘approximately $25’ at Investor Day

Introduces a mid-term Adjusted EPS target of $37.00 per diluted common share for the year ending December 31, 2025 , representing a compelling 14 percent compounded annual growth rate over the company’s updated FY 2022 Adjusted EPS outlook Expects to deliver continued earnings growth in 2026 and

PDF Version 357.8 KB